Divi's Laboratories

Company Description

Divi's Laboratories Limited is an India-based company engaged in pharmaceutical ingredients, intermediates, and nutraceutical ingredients with a focus on exports and custom synthesis. Its main businesses include manufacturing active pharmaceutical ingredients (APIs) and intermediates, and providing contract manufacturing services for global innovator companies across various therapeutic areas. The company operates in India and has subsidiaries in the USA and Europe. In the last fiscal year, the company had a market cap of $21095 million, profits of $587 million, revenue of $1095 million, and 18300 employees.

Analysis

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock Divi's Laboratories are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Divi's Laboratories. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 81% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 99 which means that the company has a financing structure that is safer than 99% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 7 which means that the share price of Divi's Laboratories is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 93% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 22, which means that professional investors are more pessimistic about the stock than for 78% of alternative investment opportunities. ...read more

Country

India

Industry Life Sciences Tools & Services

Size Small

Website divislabs.com

Index

CNX Nifty 50

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.